FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

713642004: Miltefosine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2016. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3294359017 Miltefosine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3297219011 Miltefosine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
376281000195113 miltefosina it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
30821000188115 miltéfosine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Miltefosine (substance) Is a Phospholipid true Inferred relationship Some
Miltefosine (substance) Is a Antineoplastic agent (substance) true Inferred relationship Some
Miltefosine (substance) Is a Substance with antileishmanial mechanism of action false Inferred relationship Some
Miltefosine (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antileishmanial false Inferred relationship Some
Miltefosine (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antiprotozoal true Inferred relationship Some
Miltefosine (substance) Is a Antiprotozoal true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing miltefosine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Miltefosine (substance) Inferred relationship Some 1
Product containing miltefosine in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Miltefosine (substance) Inferred relationship Some 1
Miltefosine only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Miltefosine (substance) Inferred relationship Some 1
Miltefosine only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Miltefosine (substance) Inferred relationship Some 1
Miltefosine 50 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Miltefosine (substance) Inferred relationship Some 1
Miltefosine 50 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Miltefosine (substance) Inferred relationship Some 1
Product containing precisely miltefosine 10 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Miltefosine (substance) Inferred relationship Some 1
Product containing precisely miltefosine 10 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Miltefosine (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start